CG
PTLA

Cutler Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Cutler Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,000
Closed -$29K – 4993
2019
Q2 		$29K Buy
+5,000
New +$157K ﹤0.01% 1949
2019
Q1 		– Sell
-11,800
Closed -$16K – 5073
2018
Q4 		$16K Buy
11,800
+2,000
+20% +$41.1K ﹤0.01% 2283
2018
Q3 		$12K Buy
9,800
+6,900
+238% +$225K ﹤0.01% 2571
2018
Q2 		$19K Sell
2,900
-17,400
-86% -$666K ﹤0.01% 2243
2018
Q1 		$28K Buy
20,300
+12,300
+154% +$540K ﹤0.01% 2055
2017
Q4 		$70K Sell
8,000
-4,200
-34% -$212K ﹤0.01% 1624
2017
Q3 		$119K Sell
12,200
-94,100
-89% -$5.52M ﹤0.01% 1526
2017
Q2 		$1.14M Buy
106,300
+84,000
+377% +$3.36M 0.04% 373
2017
Q1 		$120K Sell
22,300
-33,700
-60% -$1.07M 0.01% 1574
2016
Q4 		$74K Buy
56,000
+17,900
+47% +$350K ﹤0.01% 2188
2016
Q3 		$74K Buy
38,100
+34,800
+1,055% +$817K ﹤0.01% 2086
2016
Q2 		$4K Sell
3,300
-53,300
-94% -$1.32M ﹤0.01% 5235
2016
Q1 		$46K Buy
56,600
+36,100
+176% +$1.15M ﹤0.01% 2427
2015
Q4 		$187K Buy
+20,500
New +$994K 0.01% 1240

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Cutler Group's PTLA Position: Q2 2020 in Review

Cutler Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 1,500 shares — an estimated $10K sold.

Cutler Group first reported a position in PTLA in Q4 2015 and held it in 18 quarters. The position peaked at $1.77M in Q3 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Cutler Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 1,500 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $10K.
  • Cutler Group first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Portola Pharmaceuticals, Inc. position peaked at $1.77M in Q3 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.